Timor-Leste launches HPV Vaccine for 11–14 years girls. With support from partners, the vaccine will help protect girls and women against cervical cancer: a common yet preventable disease.

Gavi CEO Dr Sania Nishtar looks to a bright and dynamic future for immunisation as she implements a 180-day plan for the secretariat.

Ninety-five percent of Zimbabweans know their HIV status. That means that the more than a million people living with the virus can preventively manage the risk from other dangerous infections, like TB and HPV.

Quicker outbreak response, less panic, and freer hospital beds: as new screening kits roll out, health workers in Nepal foresee a big impact on the “notorious bacterium”.

PATH’s latest Vaccine Cost Calculators specifically address the needs of middle-income countries contending with pneumococcal and rotavirus vaccine costs.

Although deaths from amoebic meningoencephalitis are rare, they could become more common because of climate change.

River blindness and the black flies that cause it torment millions in west Africa. The “slash and clear” method is an effective way to eliminate them at source.

The allocation follows a Gavi Board decision in December 2023 to approve US$ 290 million funding for the “Big Catch-Up” initiative.

Professor Dimie Ogoina was among the first to raise the alarm as mpox spread through Nigeria’s cities in 2017. VaccinesWork spoke to him and the DRC researchers tackling the latest outbreak.

Côte d’Ivoire commits to fully finance its routine immunisation programme over the next five years to ensure sustainability beyond Gavi support.

As extreme heat awareness rises, a One Health approach and robust adaptation strategies are essential for climate-resilient health systems.

Yesterday, Côte d'Ivoire made history by becoming the first country to introduce the R21 malaria vaccine into its routine immunisation programme. We spoke to the country's EPI Director to find out how they plan to roll out this lifesaver.